Huadong Medicine Co., Ltd (SHE:000963)
China
· Delayed Price · Currency is CNY 33.54
-0.21 (-0.62%)
Apr 29, 2026, 3:04 PM CST
Huadong Medicine Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | 2021 - 2017 |
| Market Capitalization | 59,189 | 69,031 | 60,553 | 72,565 | 82,087 | 70,342 | Upgrade
|
| Market Cap Growth | -7.84% | 14.00% | -16.55% | -11.60% | 16.70% | 51.35% | Upgrade
|
| Enterprise Value | 57,969 | 67,298 | 58,711 | 70,923 | 81,583 | 69,341 | Upgrade
|
| Last Close Price | 33.75 | 39.45 | 33.87 | 39.34 | 44.09 | 37.60 | Upgrade
|
| PE Ratio | 16.90 | 20.22 | 17.24 | 25.56 | 32.85 | 30.56 | Upgrade
|
| Forward PE | 13.22 | 18.98 | 19.83 | 27.57 | 30.39 | 29.34 | Upgrade
|
| PS Ratio | 1.34 | 1.58 | 1.45 | 1.79 | 2.18 | 2.04 | Upgrade
|
| PB Ratio | 2.27 | 2.74 | 2.57 | 3.36 | 4.28 | 4.15 | Upgrade
|
| P/TBV Ratio | 3.12 | 3.81 | 3.67 | 4.50 | 5.92 | 5.76 | Upgrade
|
| P/FCF Ratio | 19.55 | 25.84 | 29.96 | 31.24 | 69.06 | 29.92 | Upgrade
|
| P/OCF Ratio | 14.01 | 16.26 | 16.15 | 18.47 | 34.46 | 22.19 | Upgrade
|
| PEG Ratio | 1.44 | 1.27 | 1.27 | 1.27 | 1.27 | 1.27 | Upgrade
|
| EV/Sales Ratio | 1.32 | 1.54 | 1.40 | 1.75 | 2.16 | 2.01 | Upgrade
|
| EV/EBITDA Ratio | 11.22 | 13.34 | 11.50 | 16.43 | 21.60 | 20.91 | Upgrade
|
| EV/EBIT Ratio | 14.09 | 16.33 | 13.53 | 19.76 | 25.86 | 24.71 | Upgrade
|
| EV/FCF Ratio | 19.15 | 25.19 | 29.05 | 30.54 | 68.64 | 29.50 | Upgrade
|
| Debt / Equity Ratio | 0.08 | 0.08 | 0.13 | 0.09 | 0.14 | 0.12 | Upgrade
|
| Debt / EBITDA Ratio | 0.42 | 0.41 | 0.58 | 0.44 | 0.67 | 0.61 | Upgrade
|
| Debt / FCF Ratio | 0.71 | 0.80 | 1.50 | 0.83 | 2.17 | 0.89 | Upgrade
|
| Net Debt / Equity Ratio | -0.06 | -0.12 | -0.09 | -0.13 | -0.07 | -0.11 | Upgrade
|
| Net Debt / EBITDA Ratio | -0.31 | -0.58 | -0.44 | -0.63 | -0.37 | -0.59 | Upgrade
|
| Net Debt / FCF Ratio | -0.52 | -1.10 | -1.11 | -1.17 | -1.19 | -0.83 | Upgrade
|
| Asset Turnover | 1.11 | 1.13 | 1.17 | 1.26 | 1.30 | 1.35 | Upgrade
|
| Inventory Turnover | 5.75 | 5.72 | 6.18 | 6.25 | 6.07 | 5.96 | Upgrade
|
| Quick Ratio | 1.21 | 1.15 | 1.15 | 1.28 | 1.23 | 1.21 | Upgrade
|
| Current Ratio | 1.67 | 1.62 | 1.53 | 1.71 | 1.73 | 1.67 | Upgrade
|
| Return on Equity (ROE) | 13.80% | 14.00% | 15.48% | 13.97% | 14.02% | 14.56% | Upgrade
|
| Return on Assets (ROA) | 6.48% | 6.70% | 7.60% | 6.94% | 6.78% | 6.85% | Upgrade
|
| Return on Invested Capital (ROIC) | 14.98% | 16.07% | 17.55% | 16.10% | 16.09% | 16.02% | Upgrade
|
| Return on Capital Employed (ROCE) | 15.30% | 15.90% | 18.00% | 15.80% | 15.00% | 15.80% | Upgrade
|
| Earnings Yield | 5.92% | 4.95% | 5.80% | 3.91% | 3.04% | 3.27% | Upgrade
|
| FCF Yield | 5.11% | 3.87% | 3.34% | 3.20% | 1.45% | 3.34% | Upgrade
|
| Dividend Yield | 2.72% | 2.36% | 2.75% | 1.47% | 0.66% | 0.77% | Upgrade
|
| Payout Ratio | 48.88% | 49.56% | 48.47% | 20.93% | 23.07% | 19.99% | Upgrade
|
| Buyback Yield / Dilution | 0.02% | -0.06% | -0.08% | -0.10% | -0.00% | 0.00% | Upgrade
|
| Total Shareholder Return | 2.67% | 2.30% | 2.66% | 1.37% | 0.66% | 0.78% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.